Decitabine increased cisplatin's NOXA-mediated pro-apoptotic effect on breast cancer cell lines, demonstrating decitabine's good clinical potential in combination with cisplatin for the treatment of triple-negative breast cancers.84 The gene discussed is PMAIP1; the disease is triple-negative breast carcinoma.